Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Earlier stage biotechs attract partners

Article Abstract:

The big pharmacy companies are acquiring earlier stage biotech companies to carry on their drug development programs smoothly, without any financial trouble. Biotech companies, whose lead programs are at or near the phase 2 clinical trial inflection point are the potential companies considered for acquisition by the pharma companies.

Author: Ratner, Mark
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Financial management, Finance, Company financing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Effecting a comprehensive intellectual property strategy using the Madrid protocol

Article Abstract:

The importance of trademarks in the biotech and pharma industries along with the ways in which companies can use the Madrid Protocol to acquire global trademark protection are described. The biggest advantage of Madrid Protocol is the ability to file an international application in a single language.

Author: Simmons, William J.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Evaluation, Trademark law

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Changing patent strategies: what will they mean for the industry?

Article Abstract:

The impact of the decline in DNA-based patent applications on the anti-commons effect is described.

Author: Mills, Ann E., Tereskerz, Patti M.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Patent Owners & Lessors, Lessors of Nonfinancial Intangible Assets (except Copyrighted Works), Patent owners and lessors, Methods, Patent licenses, Patent licensing, Genetic research, Patent licencing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Laws, regulations and rules, Biotechnology industry, Pharmaceutical industry, Biotechnology industries, Government regulation
Similar abstracts:
  • Abstracts: 704(c) gain in partnership mergers. Compliance challenges faced by pass-through entities and tax administrators: the search for uniformity continues
  • Abstracts: Partnerships: for better, for worse? Driving privately financed projects in Australia: what makes them tick? The social construction of financial statement elements under Private Finance Initiative schemes
  • Abstracts: Insurance and mortgage regulation coming your way. Free-market mortgages: don't ignore the hazards. Opportunities and threats
  • Abstracts: Proposal would defer tax bite on Navy shipbuilders. Shipbuilders mount lobbying effort with newly elected lawmakers
  • Abstracts: Economic hope may curb N. Korean nukes appetite. China fears North Korean Nuclear capability spread to Taiwan
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.